.Vaxcyte unveiled what experts called "remarkable" stage 1/2 records for its 31-valent pneumococcal ...
.Recursion has actually stumbled by means of an early examination of its tech-enabled method to drug...
.Phone it an instance of really good chemical make up: Acepodia, a biotech based on Nobel Prize-winn...
.Praxis Preciseness Medicines has actually scored another midphase gain in epilepsy this year, with ...
.After leaving a medical grip numerous years back, Dyne Therapeutics has shown brand-new period 1/2 ...
.Arrowhead Pharmaceuticals has actually shown its own hand in advance of a potential face-off along ...
.Pfizer and Valneva may possess regarding 2 more years to hang around before they help make the firs...
.Let's dive into a discussion along with Ayla Ellison, Tough Biotech Managing Editor and Michelle Be...
.Bayer put on hold the phase 3 test for its aspect XIa inhibitor asundexian late last year after the...
.Sanofi is still bented on taking its own numerous sclerosis (MS) med tolebrutinib to the FDA, execs...